CClinicalTrials.gg
Status unknownNCT04763551Updated Feb 21, 2021

Medically Assisted Procreation and Choice of the Embryo: How Far Would French People Like to go

An observational study in Infertility, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-21.

Sponsored by University Hospital, Montpellier · Observational

The sponsor has not verified this record recently (last verified Feb 2021), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

In today's context of bioethics laws revision concerning Medically Assisted Procreation, the investigators focus on the opinion of couples resorting to In Vitro Fertilization on a fundamental, much debated issue ; the choice of the embryo.

French lawmakers fear the investigators might be drifting towards embryo selection procedures, but no study allows us to state this is what patients request. This study aims at determining, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics.

02

Conditions studied

  • Infertility

Browse trials for

Keywords

  • Couple infertility with IVF indication
  • Genetic indication for PGD in France
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 300 is above the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male and female IVF patients in the MAP centers of Montpellier University Hospital, Jeanne de Flandres in Lille, and Foch Hospital in Paris (on request)

Inclusion criteria

  • Male and female IVF patients in the MAP

Exclusion criteria

Exclusion criteria:

  • Patient not fluent in French
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Rate of Medically Assisted Procreation

    Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics

    Time frame: 1 day

Secondary outcomes

  1. Determine the type of embryo genetic selection

    Determine the type of embryo genetic selection those patients request

    Time frame: 1 day

  2. Determine, among the population of patients who resort to Medically Assisted Procreation in France

    Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics, according to the type of MAP (classical MAP, with or without gamete donation, MAP with PGD)

    Time frame: 1 day

07

Study locations

1 site
  • Uhmontpellier
    Montpellier, 34295, France
08

References and documents

Individual participant data

Plan to share: Undecided — NC

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04763551
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Feb 21, 2021
Start date
Feb 1, 2021
Primary completion
Dec 1, 2021 (estimated)
Completion
Jan 1, 2022 (estimated)
Last update
Feb 21, 2021

Study contacts

Noémie Ranisavljevic, M.D., Ph.D
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion